Are the anatomical, clinical, and ultrasound characteristics of thyroid nodules with Bethesda III or IV cytology and ACR TI-RADS 3, 4, or 5 able to refine the indications for molecular diagnostic tests?
Arch. endocrinol. metab. (Online)
; 65(5): 625-631, 2021. tab
Article
de En
| LILACS
| ID: biblio-1345189
Bibliothèque responsable:
BR1.1
ABSTRACT
ABSTRACT Objective:
To analyze the association of clinical, anatomical, and ultrasound (US) characteristics of malignancies in Bethesda III or IV (III-B or IV-B) thyroid nodules. Subjects andmethods:
The association between malignancies and the following variables were analyzed III-B or IV-B, age < 55 years and ≥ 55 years, sex, family history of thyroid cancer, history of irradiation, nodule size, and ACR TI-RADS classification in 62 participants who underwent thyroidectomy.Results:
Of the 62 participants, 87.1% (54/62) were women, 74.2% were < 55 years old, 95.2% had no family history of thyroid cancer, 56.5% had nodules < 2 cm in size, 62.9% were IV-B, and 69.4% were ACR TI-RADS 4. Thirty-two patients had thyroid carcinoma, and 30 had benign histology. Among all factors associated with malignancy, only ACR TI-RADS 5 classification on US was found to be statistically significant (p = 0.014), while III-B with architectural atypia cytological classification was the only one significantly associated with benign status (p = 0.004).Conclusion:
Only a high risk of malignancy as assessed using US was able to refine the indication for molecular tests in a group of patients with indeterminate nodules. We found 85% (53/62) of III-B or IV-B thyroid nodules would benefit from available molecular diagnostic tests.Mots clés
Texte intégral:
1
Indice:
LILACS
Sujet Principal:
Tumeurs de la thyroïde
/
Nodule thyroïdien
Type d'étude:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limites du sujet:
Female
/
Humans
langue:
En
Texte intégral:
Arch. endocrinol. metab. (Online)
Thème du journal:
ENDOCRINOLOGIA
/
METABOLISMO
Année:
2021
Type:
Article